Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.02.17
重大信息内部报告制度(2011年2月)
2011.02.17
第二届监事会第一次聚会决议通告
2011.02.17
第二届董事会第一次聚会决议通告
2011.02.17
内幕信息知情人挂号和报备制度(2011年2月)
2011.01.11
关于召开2011年第一次暂时股东大会的通知通告
2011.01.11
关于公司专项治理运动的自查事项说明
2011.01.11
关于公司专项治理的自查报告和整改妄想
2011.01.11
中国建银投资证券有限责任公司关于《深圳市Z6尊龙药业股份有限公司关于公司专项治理的自...
2011.01.11
自力董事候选人声明(解冻)
2011.01.11
第一届董事会第二十三次聚会决议通告
第一页
上一页
141
142
143
144
145
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】